$WEWA
WEWARDS, INC.

2024 Q2 Form 10-Q Financial Statement

#000107997324000538 Filed on April 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $13.23K $14.43K
YoY Change -76.83% -75.05%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $13.23K $14.43K
YoY Change -76.83% -75.04%
Operating Profit -$14.43K
YoY Change -75.04%
Interest Expense -$127.4K $130.9K
YoY Change 0.19% -202.22%
% of Operating Profit
Other Income/Expense, Net -$126.1K
YoY Change -1.54%
Pretax Income -$140.7K -$140.5K
YoY Change -23.68% -24.41%
Income Tax
% Of Pretax Income
Net Earnings -$140.7K -$140.5K
YoY Change -23.68% -24.41%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 107.5M shares 107.5M shares
Diluted Shares Outstanding 107.5M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $764.2K $771.4K
YoY Change -14.08% -19.37%
Cash & Equivalents $764.2K $771.4K
Short-Term Investments
Other Short-Term Assets $490.00 $1.650K
YoY Change -16.95% -1.79%
Inventory
Prepaid Expenses $487.00 $1.649K
Receivables
Other Receivables
Total Short-Term Assets $764.7K $773.0K
YoY Change -14.08% -19.34%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $764.7K $773.0K
Total Long-Term Assets $0.00 $0.00
Total Assets $764.7K $773.0K
YoY Change -14.08% -19.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.00 $100.00
YoY Change 0.0% -99.39%
Accrued Expenses $3.521M $3.389M
YoY Change 17.58% 18.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $10.50M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.521M $13.89M
YoY Change -35.92% 382.48%
LONG-TERM LIABILITIES
Long-Term Debt $10.50M $0.00
YoY Change 31.25% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $10.50M $0.00
YoY Change 31.25% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.521M $13.89M
Total Long-Term Liabilities $10.50M $0.00
Total Liabilities $14.02M $13.89M
YoY Change 3.9% 3.81%
SHAREHOLDERS EQUITY
Retained Earnings -$18.53M -$18.38M
YoY Change 3.65% 3.93%
Common Stock $107.5K $107.5K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.26M -$13.12M
YoY Change
Total Liabilities & Shareholders Equity $764.7K $773.0K
YoY Change -14.08% -19.34%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$140.7K -$140.5K
YoY Change -23.68% -24.41%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$7.170K -$8.800K
YoY Change -89.34% -84.47%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -7.170K -8.800K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -7.170K -8.800K
YoY Change -89.34% -84.47%
FREE CASH FLOW
Cash From Operating Activities -$7.170K -$8.800K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 us-gaap Revenues
Revenues
usd
CY2023Q1 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
WEWA Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
889405 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
587 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
889992 usd
CY2023Q2 us-gaap Assets
Assets
889992 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
100 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
3388577 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2994467 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
10500000 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2500000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5494567 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8000000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
13494567 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107483450 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107483450 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
107483 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5161532 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17873590 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12604575 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
889992 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
734 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6691 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2114 usd
CY2024Q1 WEWA Rent Expense
RentExpense
38 usd
CY2023Q1 WEWA Rent Expense
RentExpense
45000 usd
WEWA Rent Expense
RentExpense
75038 usd
WEWA Rent Expense
RentExpense
135000 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
11250 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
12097 usd
us-gaap Professional Fees
ProfessionalFees
50887 usd
us-gaap Professional Fees
ProfessionalFees
51104 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
14432 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
57831 usd
us-gaap Operating Expenses
OperatingExpenses
132616 usd
us-gaap Operating Expenses
OperatingExpenses
188218 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-14432 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-57831 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-132616 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-188218 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
130891 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
129453 usd
us-gaap Interest Expense
InterestExpense
394110 usd
us-gaap Interest Expense
InterestExpense
392672 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
4809 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
1402 usd
us-gaap Interest Income Other
InterestIncomeOther
15649 usd
us-gaap Interest Income Other
InterestIncomeOther
4504 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-126082 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-128051 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-378461 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-388168 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-140514 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-185882 usd
us-gaap Net Income Loss
NetIncomeLoss
-511077 usd
us-gaap Net Income Loss
NetIncomeLoss
-576386 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107483450 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107483450 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107483450 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107483450 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107483450 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107483450 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107483450 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107483450 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-12975138 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-13115652 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-12234389 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-185882 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-12420271 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12604575 usd
us-gaap Net Income Loss
NetIncomeLoss
-511077 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-13115652 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-11843885 usd
us-gaap Net Income Loss
NetIncomeLoss
-576386 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-12420271 usd
us-gaap Net Income Loss
NetIncomeLoss
-511077 usd
us-gaap Net Income Loss
NetIncomeLoss
-576386 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1062 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1375 usd
WEWA Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-130608 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1350 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
394110 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
392672 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-130608 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-118029 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-183739 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-118029 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-183739 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
889405 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1140382 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
771376 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
956643 usd
CY2015Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
6000000 shares
CY2015Q2 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.738 pure
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8130000 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8130000 shares
CY2015Q2 WEWA Sale Of Stock Number Of Share Issued In Transaction
SaleOfStockNumberOfShareIssuedInTransaction
340000 usd
CY2015Q2 WEWA Number Of Common Shares Sold Through Stock Purchase Agreement
NumberOfCommonSharesSoldThroughStockPurchaseAgreement
6000000 shares
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zljdl5yYXP6j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_z0bEjL2lB7wg">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zbl4jh8vZijd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_860_zyLkNC99KnM7">Concentrations of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20240229_zuVhsa5sU945" title="FDIC insured amount">250,000</span> under current regulations. The Company had approximately $<span id="xdx_90D_eus-gaap--CashUninsuredAmount_iI_c20240229_zTN4DFwwtRE7" title="Excess of FDIC insured limits">521,376</span> and $<span id="xdx_902_eus-gaap--CashUninsuredAmount_iI_c20230531_zJ9kREkECVH7" title="Excess of FDIC insured limits">640,755</span> in excess of FDIC insured limits at February 29, 2024 and May 31, 2023, respectively. The Company has not experienced any losses in such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
521376 usd
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
640755 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18384667 usd
CY2024Q1 WEWA Working Capital
WorkingCapital
-13115652 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
10500000 usd
CY2023Q2 us-gaap Convertible Debt
ConvertibleDebt
10500000 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
10500000 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2500000 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8000000 usd
us-gaap Interest Expense
InterestExpense
394110 usd
us-gaap Interest Expense
InterestExpense
392672 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9013000 usd

Files In Submission

Name View Source Status
0001079973-24-000538-index-headers.html Edgar Link pending
0001079973-24-000538-index.html Edgar Link pending
0001079973-24-000538.txt Edgar Link pending
0001079973-24-000538-xbrl.zip Edgar Link pending
ex31x.htm Edgar Link pending
ex32x1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wewa-20240229.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
wewa-20240229_cal.xml Edgar Link unprocessable
wewa-20240229_def.xml Edgar Link unprocessable
wewa-20240229_lab.xml Edgar Link unprocessable
wewa-20240229_pre.xml Edgar Link unprocessable
wewa_10q-022924.htm Edgar Link pending
wewa_10q-022924_htm.xml Edgar Link completed